iBio Inc (IBIO) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

IBIO iBio Inc

Watchlist

2.6700
+0.0800+3.09%

Close Nov 1 16:00 ET

2.5700
-0.1000-3.75%

Post 19:26 ET

24.40MMarket Cap-410P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | IBio And AstralBio Say They 'Have Identified a Molecule With Therapeutic Potential for Treating Muscle Wasting and Obesity, Which Is Designed for Subcutaneous Administration and Has Potential for an Extended Half-life'; Are Working On Plans To Advance...
BenzingaOct 10 08:06 ET
Express News | Ibio Inc - Has Exclusive Option to License Three Cardiometabolic Targets From Astralbio
ReutersOct 10 08:02 ET
Express News | Ibio Inc - Aims to File Ind Application for Myostatin Program by End of 2025
ReutersOct 10 08:01 ET
Express News | Ibio Inc - Plans Non-Cgmp in Vivo Studies With Early 2025 Readouts
ReutersOct 10 08:01 ET
Express News | Ibio and Astralbio Provide Update on Myostatin Program for Obesity
ReutersOct 10 08:00 ET
IBio and AstralBio Provide Update on Myostatin Program for Obesity
GlobeNewswireOct 10 08:00 ET

Comments

Trytosaveabit

Oct 10 07:02

Update

$iBio Inc (IBIO.US)$ Ibio Inc - Aims to File Ind Application for Myostatin Program by End of 2025

$Inovio Pharmaceuticals (INO.US)$ $iBio Inc (IBIO.US)$
On Friday, the fear of human-to-human spread grew ever so slightly: The CDC confirmed that four health-care workers in Missouri had fallen sick after caring for a patient who was infected with bird flu.